Haloperidol impurity 6
Based on 20 publication(s) in Google Scholar
Haloperidol impurity 6 (Haloperidol hydrobromide) is an impurity of Haloperidol.
For research use only. We do not sell to patients.
- CAS No.: 3850-97-3
- Formula: C21H24BrClFNO2
- Molecular Weight:456.78
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Haloperidol impurity 6
More- Cell. 2023 Nov 22;186(24):5347-5362.e24. [Abstract]
- Adv Sci (Weinh). 2025 Sep;12(33):e02276. [Abstract]
- Environ Sci Technol. 2023 Sep 26;57(38):14162-14172. [Abstract]
- Acta Biomater. 2026 Jun:216:333-347. [Abstract]
- Phytomedicine. 2025 Jun:141:156707. [Abstract]
- Br J Pharmacol. 2021 Sep;178(17):3570-3586. [Abstract]
- Oncogenesis. 2025 Aug 21;14(1):31. [Abstract]
- J Ethnopharmacol. 2021 Jun 12:273:113994. [Abstract]
- Eur J Pharmacol. 2023 Dec 15:961:176174. [Abstract]
- Eur J Pharmacol. 2023 May 5:946:175647. [Abstract]
- Cell Rep Methods. 2023 Oct 23;3(10):100599. [Abstract]
- ACS Omega. 2025 Oct 17;10(42):50208-50217. [Abstract]
- ACS Omega. 2020 Nov 15;5(46):29935-29942. [Abstract]
- PLoS Negl Trop Dis. 2019 Aug 20;13(8):e0007681. [Abstract]
- BMC Endocr Disord. 2021 Nov 23;21(1):235. [Abstract]
- Clin Exp Pharmacol Physiol. 2021 Mar;48(3):370-380. [Abstract]
- Eur J Integr Med. 2021, 101322.
- Clin Tradit Med Pharmacol. 2026 Jan 14.
- University of South Carolina. 2025.
- University of Zurich. 2025.
-
WB
-
WB
-
Cell Proliferation/Viability Assay
-
Cell Imaging/Staining
-
WB
Biological Activity
Chemical Information
-
CAS No. 3850-97-3
-
Molecular Weight 456.78
-
Formula C21H24BrClFNO2
-
SMILES
O=C(CCCN1CCC(C2=CC=C(C=C2)Cl)(CC1)O)C3=CC=C(C=C3)F.Br
-
Synonyms
Haloperidol hydrobromide
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (20)
-
Journal Impact Factor
-
Most Recent
-
Cell
2023 Nov 22;186(24):5347-5362.e24. PMID: 37963465 -
Adv Sci (Weinh)
Dopamine D1 Receptor Contributes to Glucocorticoid-Associated Osteonecrosis of Femoral Head Protection Through the ATF3/CHOP Axis to Inhibit Osteoblastic Apoptosis. [Abstract]2025 Sep;12(33):e02276. PMID: 40583147
Haloperidol impurity 6 purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 Sep;12(33):e02276. [Abstract]
Western blotting of DRD1, ALP, OCN, BAX, Bcl2, cleaved‐caspase3, and β‐actin in osteogenesis‐induced BMSCs treated with Haloperidol (1 µM), DA and then stimulated with MP.
-
Environ Sci Technol
2-Ethylhexyl Diphenyl Phosphate Causes Obesity in Zebrafish by Stimulating Overeating via Inhibition of Dopamine Receptor D2. [Abstract]2023 Sep 26;57(38):14162-14172. PMID: 37704188 -
Acta Biomater
Carrier-free spherical nucleic acids engineered by coordination-competition for programmable release and cancer immunotherapy. [Abstract]2026 Jun:216:333-347. PMID: 41962730 -
Phytomedicine
Valproic acid promotes transcriptional activation of Drd2 by mediating histone acetylation to inhibit the mTOR-Pttg1 signaling axis and exerts anti-PitNETs activity. [Abstract]2025 Jun:141:156707. PMID: 40220407 -
Br J Pharmacol
Exploiting D2 receptor β-arrestin2-biased signalling to suppress tumour growth of pituitary adenomas. [Abstract]2021 Sep;178(17):3570-3586. PMID: 33904172 -
Oncogenesis
Peroxisomal lipid metabolism inhibits Pimozide-induced cancer cell death by regulating ATP homeostasis. [Abstract]2025 Aug 21;14(1):31. PMID: 40841534 -
J Ethnopharmacol
Total barley maiya alkaloids inhibit prolactin secretion by acting on dopamine D2 receptor and protein kinase A targets. [Abstract]2021 Jun 12:273:113994. PMID: 33711439 -
Eur J Pharmacol
A novel dopamine D2 receptor-NR2B protein complex might contribute to morphine use disorders. [Abstract]2023 Dec 15:961:176174. PMID: 37939993 -
Eur J Pharmacol
Sigma-1 receptor agonist properties that mediate the fast-onset antidepressant effect of hypidone hydrochloride (YL-0919). [Abstract]2023 May 5:946:175647. PMID: 36898424 -
Cell Rep Methods
RECOVER identifies synergistic drug combinations in vitro through sequential model optimization. [Abstract]2023 Oct 23;3(10):100599. PMID: 37797618 -
ACS Omega
2025 Oct 17;10(42):50208-50217. PMID: 41179162
Haloperidol impurity 6 purchased from MedChemExpress. Usage Cited in: ACS Omega. 2025 Oct 17;10(42):50208-50217. [Abstract]
Haloperidol (Halo; 20 ng/mL; 24 h). ISR induction by various drugs. N2a cells were treated with the indicated drugs for 24 h. The cell extracts were analyzed by Western blot analysis with anti-ATF4, anti-CHOP, and anti-β actin antibodies.
-
ACS Omega
Computational Approaches to Identify Molecules Binding to Mycobacterium tuberculosis KasA. [Abstract]2020 Nov 15;5(46):29935-29942. PMID: 33251429 -
PLoS Negl Trop Dis
Identification of anti-flaviviral drugs with mosquitocidal and anti-Zika virus activity in Aedes aegypti. [Abstract]2019 Aug 20;13(8):e0007681. PMID: 31430351 -
BMC Endocr Disord
The role of MAPK11/12/13/14 (p38 MAPK) protein in dopamine agonist-resistant prolactinomas. [Abstract]2021 Nov 23;21(1):235. PMID: 34814904 -
Clin Exp Pharmacol Physiol
Dopamine receptor D2 inhibition alleviates diabetic hepatic stellate cells fibrosis by regulating the TGF-β1/Smads and NFκB pathways. [Abstract]2021 Mar;48(3):370-380. PMID: 33179312
Haloperidol impurity 6 purchased from MedChemExpress. Usage Cited in: Clin Exp Pharmacol Physiol. 2021 Mar;48(3):370-380. [Abstract]
Haloperidol (10 μM; 48 h). Cell viability was measured by CCK-8 assay. The cells incubated with control medium were considered 100% viable.
Haloperidol impurity 6 purchased from MedChemExpress. Usage Cited in: Clin Exp Pharmacol Physiol. 2021 Mar;48(3):370-380. [Abstract]
Haloperidol (10 μM; 48 h). ROS production in HSCs measured by staining with DCFH-DA and imaged by fluorescent microscopy.
Haloperidol impurity 6 purchased from MedChemExpress. Usage Cited in: Clin Exp Pharmacol Physiol. 2021 Mar;48(3):370-380. [Abstract]
Haloperidol (10 μM; 48 h). Immunoblotting and optical density analysis of DRD2 and NOX-5, and the data were normalized to GAPDH.
-
-
-
-
Purity & Documentation
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)